MT Newswires
Canaccord Genuity Upgrades BioMarin Pharmaceutical to Buy From Hold, Adjusts Price Target to $98 From $84
📊
AI Sentiment
Positive
7/10
Latest updates and market news for BMRN
AI Sentiment
Positive
7/10
Share this news page